Kane Biotech Inc.

KNE.V·TSXV·Healthcare
Compare
0.03000.0000 (0.00%)today
As of Oct 22, 9:30 AM EDT · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0300
Open0.0300
Day range—
52-week range0.02000.0500
Off day high0.00%
Off 52-week high−40.00%
Volume40.30K
Avg. volume (3M)87.15K
Market cap6.15M
EPS (TTM)-0.0200
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.24
Shares outstanding205.06M
Short interest—
Earnings dateNov 26, 2026 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
KNE.V IOT.V CLGN NIKI BLRX ET80.F
Market cap 6.15M 3.54M 7.03M 6.05M 10.30M 5.35M
P/E (TTM) — — — — — —
Forward P/E — — -9.5 — -0.8 —
Price/book -6.0 1.4 1.8 0.1 0.7 0.4
Dividend yield — — — — — —
1-year change −25.00% −68.18% −83.49% −86.67% −42.35% −14.10%
Today 0.00% 0.00% −0.93% −3.00% −1.90% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All KNE.V news ›
GlobeNewswire News Room·Positive

Kane Biotech Signs Distribution Agreement with The Stevens Company

October 20, 2026 07:05 ET | Source: Kane Biotech Inc. Kane Biotech Inc. Expands Kane Biotech’s commercial footprint and access to the revyve® product line across Canada Under the agreement, Stevens will be authorized to purchase and resell…

mykxlg.com·Positive

Kane Biotech Announces $250,000 Insider Loan

The Loan does not bear interest and is repayable on demand. No bonus was paid or is payable by the Company in connection with the Loan. The Company intends to use the proceeds for general working capital and corporate purposes and intends…

From articles in the 4Search news index.

In the news

14mentions in 30 days
14with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.